Literature DB >> 17397047

The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online.

Kaate R J Vanmolkot1, Elena Babini, Boukje de Vries, Anine H Stam, Tobias Freilinger, Gisela M Terwindt, Lisa Norris, Joost Haan, Rune R Frants, Nabih M Ramadan, Michel D Ferrari, Michael Pusch, Arn M J M van den Maagdenberg, Martin Dichgans.   

Abstract

Familial hemiplegic migraine (FHM) is a severe subtype of migraine with hemiparesis during attacks. We scanned 10 families with FHM without mutations in the CACNA1A (FHM1) and ATP1A2 (FHM2) genes. We identified the novel p.L1649Q mutation (c.4946T>A) in Na(v)1.1 sodium channel gene SCN1A (FHM3) in a North American kindred with FHM without associated ataxia or epilepsy. Functional analysis of the mutation, introduced in the highly homologous human SCN5A, revealed markedly slowed inactivation and a two-fold faster recovery from fast inactivation predicting enhanced neuronal excitation. Our findings establish the role of neuronal Na(v)1.1 sodium channels in FHM and reinforce the involvement of ion channel dysfunction in the pathogenesis of this episodic brain disorder. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397047     DOI: 10.1002/humu.9486

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  31 in total

Review 1.  Identification of molecular genetic factors that influence migraine.

Authors:  Bridget H Maher; Lyn R Griffiths
Journal:  Mol Genet Genomics       Date:  2011-04-26       Impact factor: 3.291

2.  Ranolazine selectively blocks persistent current evoked by epilepsy-associated Naν1.1 mutations.

Authors:  Kristopher M Kahlig; Irene Lepist; Kwan Leung; Sridharan Rajamani; Alfred L George
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 3.  Dysfunctional Nav1.5 channels due to SCN5A mutations.

Authors:  Dan Han; Hui Tan; Chaofeng Sun; Guoliang Li
Journal:  Exp Biol Med (Maywood)       Date:  2018-05-27

Review 4.  Migraine-associated risks and comorbidity.

Authors:  H C Diener; M Küper; T Kurth
Journal:  J Neurol       Date:  2008-09-30       Impact factor: 4.849

5.  Divergent sodium channel defects in familial hemiplegic migraine.

Authors:  Kristopher M Kahlig; Thomas H Rhodes; Michael Pusch; Tobias Freilinger; José M Pereira-Monteiro; Michel D Ferrari; Arn M J M van den Maagdenberg; Martin Dichgans; Alfred L George
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-09       Impact factor: 11.205

Review 6.  Molecular genetics of migraine.

Authors:  Boukje de Vries; Rune R Frants; Michel D Ferrari; Arn M J M van den Maagdenberg
Journal:  Hum Genet       Date:  2009-05-20       Impact factor: 4.132

7.  Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects.

Authors:  Sandrine Cestèle; Emanuele Schiavon; Raffaella Rusconi; Silvana Franceschetti; Massimo Mantegazza
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

8.  Functional Effects of Schizophrenia-Linked Genetic Variants on Intrinsic Single-Neuron Excitability: A Modeling Study.

Authors:  Tuomo Mäki-Marttunen; Geir Halnes; Anna Devor; Aree Witoelar; Francesco Bettella; Srdjan Djurovic; Yunpeng Wang; Gaute T Einevoll; Ole A Andreassen; Anders M Dale
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-01-01

9.  Self-limited hyperexcitability: functional effect of a familial hemiplegic migraine mutation of the Nav1.1 (SCN1A) Na+ channel.

Authors:  Sandrine Cestèle; Paolo Scalmani; Raffaella Rusconi; Benedetta Terragni; Silvana Franceschetti; Massimo Mantegazza
Journal:  J Neurosci       Date:  2008-07-16       Impact factor: 6.167

10.  Diverse functional consequences of mutations in the Na+/K+-ATPase alpha2-subunit causing familial hemiplegic migraine type 2.

Authors:  Neslihan N Tavraz; Thomas Friedrich; Katharina L Dürr; Jan B Koenderink; Ernst Bamberg; Tobias Freilinger; Martin Dichgans
Journal:  J Biol Chem       Date:  2008-08-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.